LAMB2 and nephrotic syndrome: Transgenic podocyte-specific Lamβ1 expression in Lamb2−/− mice successfully increased LM-511 trimer deposition, eliminated nephrotic syndrome, and extended survival, highlighting a potential new therapeutic approach (111).